Prevalence, Clinical Features, and Extraintestinal Manifestations in Patients with Familial Inflammatory Bowel Diseases
Digestive Diseases and Sciences · 2025
DOI: 10.1007/s10620-025-08868-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive Diseases and Sciences, 2025. Verfasst von Christina Liava und 5 weiteren Autor:innen. Beteiligte Einrichtung: Fourth Department of Internal Medicine, Hippokration General Hospital of Thessaloniki, Aristotle University of Thessaloniki, Konstantinoupoleos Str. …. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
BACKGROUND: A positive family history is considered the strongest recognizable risk factor for developing inflammatory bowel diseases (IBD) and is present in 8-12% of cases. AIMS: To determine the prevalence of familial IBD and also to compare the clinical characteristics and extraintestinal manifestations between familial and sporadic cases. METHODS: We conducted a cross-sectional study based on retrospectively-prospectively collected data from a cohort of IBD patients followed in daily clinical practice. Patients with biopsy-confirmed familial and sporadic IBD aged 16-90 years old were included in the study. A comprehensive questionnaire was used to collect data on each site visit. Logistic regression analysis and chi-squared test were used. RESULTS: In total, 265 patients with IBD were included. 12.1% had a first-degree relative with IBD present (16.4% in Crohn's disease and 5.7% in the ulcerative colitis group, P < 0.05). Familial IBD patients were mainly females, were more frequently diagnosed with Crohn's disease and had a higher risk for hospitalization due to an IBD flare (P < 0.05), to undergo a surgical procedure (P < 0.001), to require treatment with biologic agents (P < 0.05), to develop perianal disease (P < 0.05), and extraintestinal manifestations (P < 0.05), mainly spine joint complications, erythema nodosum, and anterior uveitis. CONCLUSION: In this study, a positive family history of IBD was present in 16.4% of Crohn's disease and 5.7% of ulcerative colitis patients and was associated with a greater risk for hospitalization, surgical procedures, occurrence of perianal disease, need for treatment with biologic agents, and development of extraintestinal manifestations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Fourth Department of Internal Medicine, Hippokration General Hospital of Thessaloniki, Aristotle University of Thessaloniki, Konstantinoupoleos Str. 49, 54642, Thessaloniki, Greece. christinli@auth.gr.
- Radiology Unit, Interbalkan Medical Center of Thessaloniki, Thessaloniki, Greece.
- Fourth Department of Internal Medicine, Hippokration General Hospital of Thessaloniki, Aristotle University of Thessaloniki, Konstantinoupoleos Str. 49, 54642, Thessaloniki, Greece.
- Gastroenterology Unit, Interbalkan Medical Center of Thessaloniki, Thessaloniki, Greece.
Zitieren
APA
Liava, C., Chourmouzi, D., Sinakos, E., Dimitroulas, T., Navrozidou, C., & Akriviadis, E. (2025). Prevalence, Clinical Features, and Extraintestinal Manifestations in Patients with Familial Inflammatory Bowel Diseases. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-025-08868-5
Vancouver
Liava C, Chourmouzi D, Sinakos E, Dimitroulas T, Navrozidou C, Akriviadis E. Prevalence, Clinical Features, and Extraintestinal Manifestations in Patients with Familial Inflammatory Bowel Diseases. Digestive Diseases and Sciences. 2025. doi:10.1007/s10620-025-08868-5
BibTeX
@article{Liava2025,
author = {Liava, Christina and Chourmouzi, Danai and Sinakos, Emmanouil and Dimitroulas, Theodoros and Navrozidou, Christina and Akriviadis, Evangelos},
title = {Prevalence, Clinical Features, and Extraintestinal Manifestations in Patients with Familial Inflammatory Bowel Diseases},
journal = {Digestive Diseases and Sciences},
year = {2025},
doi = {10.1007/s10620-025-08868-5}
}
EUVIMED